Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zimin Chen

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
Plos Pathogens|November 30, 2023
Development of a bispecific nanobody conjugate broadly neutralizes diverse SARS-CoV-2 variants and structural basis for its broad neutralizationJing Yang, Sheng Lin, Zimin Chen, et al.
International Journal of Biological Macromolecules|December 20, 2025
Modification of a SARS-CoV-2 spike-RBD targeting nanobody for pH-dependent binding and its chromatographic engineering for purification of WT and variant S-RBDs with mild elution conditionsXindan Zhang, Zimin Chen, Sheng Lin, et al.
Plos Pathogens|October 13, 2023
Structural and functional basis of low-affinity SAM/SAH-binding in the conserved MTase of the multi-segmented Alongshan virus distantly related to canonical unsegmented flavivirusesHua Chen, Sheng Lin, Fanli Yang, et al.
Cell Host & Microbe|February 1, 2020
Structural Analysis of Rabies Virus Glycoprotein Reveals pH-Dependent Conformational Changes and Interactions with a Neutralizing AntibodyFanli Yang, Sheng Lin, Fei Ye, et al.
Nature Communications|December 31, 2024
Trivalent recombinant protein vaccine induces cross-neutralization against XBB lineage and JN.1 subvariants: preclinical and phase 1 clinical trialsJingyun Yang, Weiqi Hong, Huashan Shi, et al.
Signal Transduction and Targeted Therapy|February 25, 2025
A recombinant protein vaccine induces protective immunity against SARS-CoV-2 JN.1 and XBB-lineage subvariantsJingyun Yang, Weiqi Hong, Huashan Shi, et al.
Signal Transduction and Targeted Therapy|November 20, 2024
Intranasal delivery of a subunit protein vaccine provides protective immunity against JN.1 and XBB-lineage variantsHong Lei, Weiqi Hong, Jingyun Yang, et al.
Nature Communications|September 17, 2022
A self-assembled trimeric protein vaccine induces protective immunity against Omicron variantCai He, Jingyun Yang, Weiqi Hong, et al.
Nature|July 30, 2020
A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunityJingyun Yang, Wei Wang, Zimin Chen, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Plos Pathogens|November 30, 2023
Development of a bispecific nanobody conjugate broadly neutralizes diverse SARS-CoV-2 variants and structural basis for its broad neutralizationJing Yang, Sheng Lin, Zimin Chen, et al.
International Journal of Biological Macromolecules|December 20, 2025
Modification of a SARS-CoV-2 spike-RBD targeting nanobody for pH-dependent binding and its chromatographic engineering for purification of WT and variant S-RBDs with mild elution conditionsXindan Zhang, Zimin Chen, Sheng Lin, et al.
Plos Pathogens|October 13, 2023
Structural and functional basis of low-affinity SAM/SAH-binding in the conserved MTase of the multi-segmented Alongshan virus distantly related to canonical unsegmented flavivirusesHua Chen, Sheng Lin, Fanli Yang, et al.
Cell Host & Microbe|February 1, 2020
Structural Analysis of Rabies Virus Glycoprotein Reveals pH-Dependent Conformational Changes and Interactions with a Neutralizing AntibodyFanli Yang, Sheng Lin, Fei Ye, et al.
Nature Communications|December 31, 2024
Trivalent recombinant protein vaccine induces cross-neutralization against XBB lineage and JN.1 subvariants: preclinical and phase 1 clinical trialsJingyun Yang, Weiqi Hong, Huashan Shi, et al.
Signal Transduction and Targeted Therapy|February 25, 2025
A recombinant protein vaccine induces protective immunity against SARS-CoV-2 JN.1 and XBB-lineage subvariantsJingyun Yang, Weiqi Hong, Huashan Shi, et al.
Signal Transduction and Targeted Therapy|November 20, 2024
Intranasal delivery of a subunit protein vaccine provides protective immunity against JN.1 and XBB-lineage variantsHong Lei, Weiqi Hong, Jingyun Yang, et al.
Nature Communications|September 17, 2022
A self-assembled trimeric protein vaccine induces protective immunity against Omicron variantCai He, Jingyun Yang, Weiqi Hong, et al.
Nature|July 30, 2020
A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunityJingyun Yang, Wei Wang, Zimin Chen, et al.
Pageof 6